Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

NCT00055874 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1551

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: cytarabine
DRUG: hydroxyurea
DRUG: imatinib mesylate
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Heidelberg University